1
|
Huo T, Zhao X, Cheng Z, Wei J, Zhu M, Dou X, Jiao N. Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing. Acta Pharm Sin B 2024; 14:1030-1076. [PMID: 38487004 PMCID: PMC10935128 DOI: 10.1016/j.apsb.2023.11.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 10/14/2023] [Accepted: 11/13/2023] [Indexed: 03/17/2024] Open
Abstract
Synthetic chemistry plays an indispensable role in drug discovery, contributing to hit compounds identification, lead compounds optimization, candidate drugs preparation, and so on. As Nobel Prize laureate James Black emphasized, "the most fruitful basis for the discovery of a new drug is to start with an old drug"1. Late-stage modification or functionalization of drugs, natural products and bioactive compounds have garnered significant interest due to its ability to introduce diverse elements into bioactive compounds promptly. Such modifications alter the chemical space and physiochemical properties of these compounds, ultimately influencing their potency and druggability. To enrich a toolbox of chemical modification methods for drug discovery, this review focuses on the incorporation of halogen, oxygen, and nitrogen-the ubiquitous elements in pharmacophore components of the marketed drugs-through late-stage modification in recent two decades, and discusses the state and challenges faced in these fields. We also emphasize that increasing cooperation between chemists and pharmacists may be conducive to the rapid discovery of new activities of the functionalized molecules. Ultimately, we hope this review would serve as a valuable resource, facilitating the application of late-stage modification in the construction of novel molecules and inspiring innovative concepts for designing and building new drugs.
Collapse
Affiliation(s)
- Tongyu Huo
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Xinyi Zhao
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Zengrui Cheng
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Jialiang Wei
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
- Changping Laboratory, Beijing 102206, China
| | - Minghui Zhu
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Xiaodong Dou
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Ning Jiao
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
- Changping Laboratory, Beijing 102206, China
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes, East China Normal University, Shanghai 200062, China
| |
Collapse
|
2
|
Chen G, Chang Z, Yuan P, Wang S, Yang Y, Liang X, Zhao D. Late-stage functionalization of 5-nitrofurans derivatives and their antibacterial activities. RSC Adv 2023; 13:3204-3209. [PMID: 36756397 PMCID: PMC9853512 DOI: 10.1039/d2ra07676d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Accepted: 01/16/2023] [Indexed: 01/21/2023] Open
Abstract
Structure modification of drugs is a reliable way to optimize lead compounds, among which the most striking and direct method is late-stage functionalization (LSF). Here, we employed the Cu-catalyzed C-H LSF to modify 5-nitrofuran drugs. A series of modifications have been carried out including hydroxylation, methylation, azidination, cyanation, arylation, etc. Antibacterial activities of all compounds in vitro were measured. The results showed that compound 1 and compound 18 were the most active among all compounds. Meanwhile, the cell cytotoxicity assays of potent compounds 1, 3, 4, 5 & 18 and the parent drug FZD were conducted.
Collapse
Affiliation(s)
- Geshuyi Chen
- The First Clinical Medical College, Lanzhou University Lanzhou China
| | - Zhe Chang
- Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou China
| | - Pei Yuan
- The First Clinical Medical College, Lanzhou University Lanzhou China
| | - Si Wang
- Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou China
| | - Yongxiu Yang
- The First Clinical Medical College, Lanzhou University Lanzhou China .,The First Clinical Medical College, Lanzhou University. Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Key Laboratory for Gynecologic Oncology Lanzhou 730000 Gansu Province China .,Lead Contact China
| | - Xiaolei Liang
- The First Clinical Medical College, Lanzhou University Lanzhou China .,The First Clinical Medical College, Lanzhou University. Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Key Laboratory for Gynecologic Oncology Lanzhou 730000 Gansu Province China
| | - Depeng Zhao
- Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou China
| |
Collapse
|
3
|
Zhao J, Huang B, Zhu B, Ma X, Mo D. Visible Light Promoted Chan‐Lam Reaction and Cycloaddition to Prepare Chromeno[4,3‐c]isoxazolidines in One‐Pot Reaction. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202100448] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Jie Zhao
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences Guangxi Normal University 15 Yu Cai Road Guilin 541004 People's Republic of China
| | - Bing‐Qing Huang
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences Guangxi Normal University 15 Yu Cai Road Guilin 541004 People's Republic of China
| | - Bin‐Can Zhu
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences Guangxi Normal University 15 Yu Cai Road Guilin 541004 People's Republic of China
| | - Xiao‐Pan Ma
- College of Pharmacy Guilin Medical University Guilin 541199 People's Republic of China
| | - Dong‐Liang Mo
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences Guangxi Normal University 15 Yu Cai Road Guilin 541004 People's Republic of China
| |
Collapse
|
4
|
Qiu X, Wang Y, Su L, Jin R, Song S, Qin Q, Li J, Zong B, Jiao N. Selective
Carbon‐Carbon
Bond Amination with
Redox‐Active
Aminating Reagents: A Direct Approach to Anilines
†. CHINESE J CHEM 2021. [DOI: 10.1002/cjoc.202100430] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Xu Qiu
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
| | - Yachong Wang
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
| | - Lingyu Su
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
| | - Rui Jin
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
- State Key Laboratory of Catalytic Materials and Reaction Engineering Research Institute of Petroleum Processing, SINOPEC 100083 Beijing China
| | - Song Song
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
| | - Qixue Qin
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
| | - Junhua Li
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
| | - Baoning Zong
- State Key Laboratory of Catalytic Materials and Reaction Engineering Research Institute of Petroleum Processing, SINOPEC 100083 Beijing China
| | - Ning Jiao
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences Peking University Beijing 100191 China
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes East China Normal University Shanghai 200062 China
| |
Collapse
|
5
|
Zhang X, Qin J, Ma R, Shi L. A base-free Chan–Lam reaction catalyzed by an easily assembled Cu(II)-carboxylate metal-organic framework. JOURNAL OF CHEMICAL RESEARCH 2021. [DOI: 10.1177/17475198211026506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A new copper(II) metal-organic framework is constructed as a sustainable copper heterogeneous catalyst. Cu-DPTCA, with high catalytic activity, can effectively promote the Chan–Lam coupling reaction of arylboronic acids and amines without adding any base or additive.
Collapse
Affiliation(s)
- Xinhai Zhang
- School of Traffic and Materials Engineering, Hebi Polytechnic, Hebi, People’s Republic of China
| | - Jianhua Qin
- College of Chemistry and Chemical Engineering, Luoyang Normal University, Luoyang, People’s Republic of China
| | - Ruixuan Ma
- Zhang Dayu School of Chemistry, Dalian University of Technology, Dalian, People’s Republic of China
| | - Lei Shi
- Zhang Dayu School of Chemistry, Dalian University of Technology, Dalian, People’s Republic of China
| |
Collapse
|
6
|
Jordan A, Stoy P, Sneddon HF. Chlorinated Solvents: Their Advantages, Disadvantages, and Alternatives in Organic and Medicinal Chemistry. Chem Rev 2020; 121:1582-1622. [DOI: 10.1021/acs.chemrev.0c00709] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Andrew Jordan
- GlaxoSmithKline Carbon Neutral Laboratory for Sustainable Chemistry, Jubilee Campus, University of Nottingham, 6 Triumph Road, Nottingham NG7 2GA, U.K
| | - Patrick Stoy
- Drug Design and Selection, Platform and Technology Sciences, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States
| | - Helen F. Sneddon
- GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K
| |
Collapse
|
7
|
Guest EE, Oatley SA, Macdonald SJF, Hirst JD. Molecular Simulation of αvβ6 Integrin Inhibitors. J Chem Inf Model 2020; 60:5487-5498. [PMID: 32421320 DOI: 10.1021/acs.jcim.0c00254] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The urgent need for new treatments for the chronic lung disease idiopathic pulmonary fibrosis (IPF) motivates research into antagonists of the RGD binding integrin αvβ6, a protein linked to the initiation and progression of the disease. Molecular dynamics (MD) simulations of αvβ6 in complex with its natural ligand, pro-TGF-β1, show the persistence over time of a bidentate Arg-Asp ligand-receptor interaction and a metal chelate interaction between an aspartate on the ligand and an Mg2+ ion in the active site. This is typical of RGD binding ligands. Additional binding site interactions, which are not observed in the static crystal structure, are also identified. We investigate an RGD mimetic, which serves as a framework for a series of potential αvβ6 antagonists. The scaffold includes a derivative of the widely utilized 1,8-naphthyridine moiety, for which we present force field parameters, to enable MD and relative free energy perturbation (FEP) simulations. The MD simulations highlight the importance of hydrogen bonding and cation-π interactions. The FEP calculations predict relative binding affinities, within 1.5 kcal mol-1, on average, of experiments.
Collapse
Affiliation(s)
- Ellen E Guest
- School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom
| | - Steven A Oatley
- School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom
| | | | - Jonathan D Hirst
- School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom
| |
Collapse
|
8
|
Huang X, Qi Y, Gu Y, Gong S, Shen G, Li Q, Li J. Imidazole-directed fabrication of three polyoxovanadate-based copper frameworks as efficient catalysts for constructing C–N bonds. Dalton Trans 2020; 49:10970-10976. [DOI: 10.1039/d0dt02162h] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Three polyoxovanadate-based copper frameworks with 3D, 2D and 1D networks have been developed and they displayed efficient heterogeneous catalytic activities in the Chan-Lam reaction.
Collapse
Affiliation(s)
- Xianqiang Huang
- Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology
- School of Chemistry & Chemical Engineering
- Liaocheng University
- Liaocheng
- China
| | - Yuquan Qi
- Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology
- School of Chemistry & Chemical Engineering
- Liaocheng University
- Liaocheng
- China
| | - Yuxiao Gu
- Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology
- School of Chemistry & Chemical Engineering
- Liaocheng University
- Liaocheng
- China
| | - Shuwen Gong
- Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology
- School of Chemistry & Chemical Engineering
- Liaocheng University
- Liaocheng
- China
| | - Guodong Shen
- Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology
- School of Chemistry & Chemical Engineering
- Liaocheng University
- Liaocheng
- China
| | - Qiang Li
- Shandong Provincial Key Laboratory of Chemical Energy Storage and Novel Cell Technology
- School of Chemistry & Chemical Engineering
- Liaocheng University
- Liaocheng
- China
| | - Jikun Li
- College of Chemistry and Chemical Engineering
- Taishan University
- Tai'an
- P. R. China
| |
Collapse
|
9
|
Robinson H, Stillibrand J, Simelis K, Macdonald SJF, Nortcliffe A. Iridium-catalysed C–H borylation of β-aryl-aminopropionic acids. Org Biomol Chem 2020. [DOI: 10.1039/d0ob01495h] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Iridium-catalysed C–H borylation of β-aryl-aminopropionic acid derivatives gives 3,5-functionalised protected β-aryl-aminopropionic acid boronates. One-pot borylation–functionalisation provides diverse building blocks for medicinal chemistry.
Collapse
Affiliation(s)
- Henry Robinson
- GlaxoSmithKline Carbon Neutral Laboratories for Sustainable Chemistry
- School of Chemistry
- University of Nottingham
- Nottingham
- UK
| | - Joe Stillibrand
- GlaxoSmithKline Carbon Neutral Laboratories for Sustainable Chemistry
- School of Chemistry
- University of Nottingham
- Nottingham
- UK
| | - Klemensas Simelis
- GlaxoSmithKline Carbon Neutral Laboratories for Sustainable Chemistry
- School of Chemistry
- University of Nottingham
- Nottingham
- UK
| | | | - Andrew Nortcliffe
- GlaxoSmithKline Carbon Neutral Laboratories for Sustainable Chemistry
- School of Chemistry
- University of Nottingham
- Nottingham
- UK
| |
Collapse
|